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Helicobacter pylori is a leading etiologic agent causing peptic ulcer and gastric cancer. The alternative 
lifestyle as a biofilm facilitates H. pylori to survive in adverse environments. Here, we investigated effect 
of curcumin on H. pylori biofilm formation both qualitatively by pellicle assay and quantitatively by 
crystal violet staining. Three-dimensional structure of biofilm was imaged by scanning electron 
microscopy. The effect of curcumin on H. pylori adherence to HEp-2 cells was also investigated. Sub-
inhibitory concentrations of curcumin inhibited the biofilm in dose dependent manner. However, H. 
pylori could restore ability to form biofilm during extended time of incubation. Scanning electron 
microscopy revealed less amorphous extracellular polymeric matrix, slow of morphological conversion 
to coccoid form with cell damage after curcumin treatment. Curcumin significantly decreased the ability 
of H. pylori to adhere to the HEp-2 cells. Our findings demonstrated advantages of curcumin to inhibit 
biofilm formation by H. pylori, making it as a potential complimentary medicine for curing of H. pylori-
biofilm related infections. 
 






Helicobacter pylori is a very common human gastro-
intestinal pathogen causing peptic ulcer disease, chronic 
gastritis and gastric cancer. Over a half of world’s 
population has been infected with this pathogen with 
estimated prevalence up to 50 and 90% in developed and 
developing countries, respectively (Dunn et al., 1997). 
The primary mode of transmission proposed for H. pylori 
is person-to-person by fecal-oral (Thomas et al., 1992), 
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(Parsonnet et al., 1999). Several recent works have 
demonstrated an alternate life style of H. pylori as a 
biofilm, which is likely to be important to facilitate bac-
terial survival in hazardous environment (Cole et al., 
2004; Stark et al., 1999). The roles of water sources and 
associated biofilms acting as environmental transmitters 
of H. pylori have been suggested by the detection of H. 
pylori in water distribution systems (Watson et al., 2004), 
drinking water (Bunn et al., 2002), groundwater (Benson 
et al., 2004), cast iron water pipe sections (Park et al., 
2001), rivers (Enroth and Engstrand, 1995) and waste 
water systems (Nayak and Rose, 2007). In vivo study has 
also demonstrated the existence of H. pylori biofilms on 
human gastric mucosa, which suggested involving in the 
pathogenicity of gastric ulcers (Carron et al., 2006). The 
presence of H. pylori in subgingival biofilm and saliva 
samples of chronic periodontitis subjects has supported 
the possibility of oral cavity being as one another possible 





reservoir of this bacterium (Souto and Colombo, 2008).  
Biofilms are defined as “complex microbial ecosystems 
adherent to each other and/or to surface or interface” 
(Donlan and Costerton, 2002). The bacterial communities 
are embedded in an exopolysaccharide matrix expanded 
laterally and vertically to form microcolonies (Cole et al., 
2004). H. pylori biofilms are exhibited in many charac-
teristics in vitro including flasks, culture tubes (Cole et al., 
2004) and in a glass fermenter (Stark et al., 1999). The 
common appearances are aggregated of bacteria not 
attached to surface (floc) (Hall-Stoodley et al., 2004) and 
form at an air-liquid interface (pellicles) (Friedman and 
Kolter, 2004). Scanning electron microscopy (SEM) re-
vealed H. pylori primarily in coccoid form stacked several 
layers thick with channels for nutrient flow. The bacteria 
tend to enter into a viable but nonculturable state (VBNC) 
(Cellini et al., 2007). The biofilm can shear off, multiply, 
disperse and colonize as planktonic individuals causing 
relapse and chronic infection (Thomas and Lehman, 
2006), which become a major concern for public health.  
Multiple drug regimens with antibiotics have been 
successively used for H. pylori treatment. However, the 
growth rate of antibiotic resistance in H. pylori is proble-
matic with 10 - 20% of treatment failure. The frequency of 
resistance to amoxicillin, clarithromycin, metronidazole 
and tetracycline ranges from approximately 2% to more 
than 45% (Romano et al., 2008). One of the important 
factors of eradication failure arises from the protective 
environment of biofilm (Lewis, 2001). The surrounded 
biofilms rescue bacteria from killing by antibiotics and 
host defense mechanisms presumably due to the differ-
rentiation and survival of persister cells or slow growth 
rate (Patel, 2005; Stewart and Costerton, 2001). The 
natural products are alternative medicine for controlling of 
antibiotic resistant bacteria. The anti-biofilm activity from 
plant extracts has been demonstrated against Candida 
albicans (Shuford et al., 2005) and Staphylococcus 
aureus (Quave et al., 2008). However, for H. pylori, only 
antimicrobial activity from various medicinal plants has 
been extensively studied. Curcuma longa is one of those 
interesting plants that possesses an extensive range of 
beneficial pharmacological effects, including anti-inflam-
matory, antimutagen, antibacterial, antiviral and antioxi-
dant effects (Araujo and Leon, 2001). Curcumin (dife-
ruloymethane) is considered as a major active 
compound, which possesses the inhibitory activity 
against 19 strains of H.  pylori in vitro with MICs range 
from 6.25-50 µg/ml (Mahady et al., 2002). It also showed 
combination effect with methanol extract of ginger root in 
inhibiting growth of H. pylori (Mahady et al., 2005). 
Although, curcumin has been prescribed for an inhibitory 
action against H. pylori, the anti-biofilm formation of this 
organism remains unknown.  
The objectives of this study aimed to investigate the 
effect of curcumin against H. pylori biofilm formation. The 
level of H. pylori biofilm formation was  determined  quail- 




tatively by pellicle assay and quantified by modified 
crystal violet staining assay in a presence and absence of 
curcumin. The cytoarchitecture in biofilm was revealed by 
standard SEM technique. Due to the first step of biofilm 
formation involves cell adhesion and colonization, the 
role of curcumin against H. pylori adhesion to HEp-2 cells 
was also investigated.   
 
 




H. pylori ATCC43504,  ATCC43526, ATCC51932 (purchased from 
the American Type Culture Collection) and DMST20165 and DMST 
20885 (obtained from the Department of Medical Sciences, 
Thailand) and clinical strains 1203, 1260, 1261, 1264, 1265, 1268, 
1275, LP25 and UT142 (kindly provided by Dr. Ratha-korn 
Vilaichone, Faculty of medicine, Thammasat University, Thailand) 
were routinely cultured on brain heart infusion (BHI) agar (Oxoid, 
UK) supplemented with 7% (v/v) sheep blood and incubated at 
37°C under microaerobic conditions (N2, 85%; O2, 5%; CO2, 10%) 
using gas generating kit (Mitsubishi, Japan).  
 
 
Screening of biofilm production  
 
All the bacteria were screened for biofilm production using pellicle 
assay as previously described (Joshua et al., 2006). Briefly, all iso-
lates were grown in 13- by 125-mm glass test tubes containing 10 
ml of BHI broth supplemented with 2% (w/v) β-cyclodextrin (BCD; 
Sigma, USA) in the presence and absence of curcumin. The final 
bacterial concentration was adjusted to an OD600 of 0.2 (~108   
CFU/ml). The cultures were incubated at 37°C for 7 days without 
shaking under microaerobic conditions. Development of pellicle 
and/or attached bacterial cells at interior surface of test tube at the 
air-liquid interface, representing as biofilm, was examined daily. 
 
 
Minimum inhibitory concentration test 
 
Minimum inhibitory concentration (MIC) was determined, in dupli-
cate, by an agar dilution method following the Clinical and Labora-
tory Standards Institute (CLSI) guidelines using Mueller-Hinton agar 
with 5% (v/v) sheep blood. The curcumin (Sigma, USA) was 
dissolved in DMSO (Sigma, USA) and serially diluted 2-fold in 
Mueller-Hinton agar (Oxoid, UK) to give final concentrations ranging 
from 0.125 to 128µg/ml. A 72-h bacterial colony of H. pylori 
ATCC43504 was harvested and suspended in sterile saline 
solution. The bacterial final concentration was adjusted equivalently 
to approximately 2.0 McFarland standard (5 x 107 CFU/ml).  Three 
microlitres of bacterial suspension per spot was replicated on each 
plate followed by incubating at 37°C for 72 h under microaerobic 
conditions. The MIC was defined as the lowest concentration of 
curcumin at which no visible growth was observed.  
 
 
Examination of effect of curcumin against H. pylori biofilm 
 
In order to determine the effect of curcumin concentration against 
H. pylori biofilm formation, curcumin were tested at various concen-
trations including 1/2, 1/4, 1/8, 1/16 and 1/32 MIC. H. pylori 
ATCC43504 was grown as described in pellicle assay for screening 
of biofilm production in an absence and presence  of  these  relative  
                                                                                                                                      




curcumin concentrations. The upmost dilution of DMSO used at 
0.016% was incorporated as control. Development of biofilm was 
examined daily until 7 days. Subsequently, the curcumin concen-
trations that displayed significant effects against biofilm formation 
were selected for further optimum treatment-time examination by 
daily observation from day 1 to day 21. 
 
 
Quantification of biofilm formation  
 
A 72-h H. pylori ATCC43504 was grown in 13- by 125-mm glass 
test tubes as described in pellicle assay in an absence and pre-
sence of various curcumin concentrations (1/2, 1/4, 1/8, 1/16 and 1/ 
32 MIC). BHI broths supplemented with 2% (w/v) BCD and DMSO 
at concentration of 0.016% were incorporated as blank and control, 
respectively. After 7-d incubation, all the culture medium was re-
moved.  The glass test tubes were then rinsed twice with PBS and 
dried for 30 min at 60°C and 10 ml of 0.1% (w/v) crystal violet was 
added for 5 min at room temperature. The unbound crystal violet 
was discarded. The glass test tubes were left to dry at 60°C for 15 
min and then washed three times with PBS. The bound crystal vio-
let was decolorized with ethanol/acetone (80:20, v/v). The level of 
biofilm formations were quantified by measuring the absorbance of 
the solution at 570 nm using a spectrophotometer (Hitachi, Japan). 
Triplicate absorbance reading for each concentration tested was 
averaged and average of the control was subtracted.  
 
 
Scanning electron microscopy (SEM) 
 
The samples were prepared for SEM including pellicles collected 
from the untreated samples at day 4, 5, 6, 7, the pellicle from 1/4 
MIC of curcumin treated at day 7 and the planktonic cells taken 
from 1/2 MIC of curcumin treated at day 7. Planktonic cells collec-
ted from BHI broth without 2% (w/v) BCD at day 7 and colonies 
grown on BHI agar supplemented with 7% (v/v) sheep blood for 3 
days were also compared. SEM was performed by Scientific and 
Tech-nological Research Equipment Center, Chulalongkorn 
University, Thailand. Briefly, the pellicles and planktonic cells were 
collected and fixed in 2.5% (v/v) glutaraldehyde in 0.1 M PBS (pH 
7.2) for 1 h. Samples were washed twice by PBS, following by 
distilled water. All samples were then successive dehydrated 
through a graded series of ethanol (10 min per step; 30, 50, 70, 90, 
3 x 100%; v/v), followed by coating with gold-palladium. Finally, the 





The HEp-2 cells (kindly provided by Dr. Pornthep Tiensiwakul, 
Faculty of Allied Health Sciences, Chulalongkorn University, Thai-
land) were grown on tissue culture plasticware in Dulbecco’s 
modified of Eagle’s medium (DMEM; Invitrogen, USA) supple-
mented with 10% (v/v) fetal bovine serum at 37°C in 5% CO2 with 
95% humidity. Approximately 3 x 106 cells were seeded on 6-well 
tissue culture plates and grown overnight to reach 80% confluence. 
A-72 h H. pylori ATCC43504 was suspended in DMEM. The bac-
terial suspension was added into each well at the final 
concentration of 3 x 108 CFU/ml followed by curcumin treatment at 
sub-MIC. The co-culture between HEp-2 cells and H. pylori without 
curcumin treatment was served as control. After incubation for 2 h, 
the cells were gently washed three times with Dulbecco’s 
phosphate buffer saline (DPBS; Invitrogen, USA) and lysed with 
sterile distilled water for 15 min on the shaking platform, at 150 rpm. 
Cell lysate solutions were serially diluted and plated out onto brain 





incubated at 37°C under microaerobic condition for 3-5 days to 
determine the number of viable bacteria. Plates containing the 





All experiments were performed independently in duplicate on three 
separated occasions. Values were expressed as mean ± SD. The 
effects of curcumin at various concentrations were quantitatively 
evaluated by one-way analysis of variance (ANOVA). The anti-
adhesion against H. pylori was compared under curcumin treated 
and untreated conditions using student’s pair t-test. Statistical signi-





Screening for biofilm formation 
 
Eleven isolates and three reference strains of H. pylori 
were preliminary screened for biofilm formation. Two cha-
racteristics of biofilm were observed on the wall of the 
culture test tubes at air-liquid interface in the form of 
pellicle and attached biofilm (Figure 1) in all tested 
strains. Development of these two biofilm characteristics 
of all H. pylori strains is shown in Table 1. The biofilm of 
three strains, including ATCC43504, ATCC43526 and 
1264, could be observed on day 3 of incubation. Almost 
strains, except ATCC51932, DMST20165 and LP25, 
were able to form biofilm after 4 days of incubation. At the 
end of incubation period, nine strains of H. pylori pro-
duced extensive level of biofilms whereas 4 of the strains 
formed intermediate levels. Only one strain, ATCC51932, 
developed low biofilm level in this study. 
 
 
Inhibitory effect of curcumin on H. pylori biofilm  
 
Curcumin was capable to inhibit the growth of H. pylori 
ATCC43504 at an MIC value of 16 µg/ml. The concen-
trations of curcumin at sub-inhibitory level (1/2, 1/4, 1/8, 
1/16 and 1/32 MIC) were used for biofilm assay. Their 
inhibitory effects on biofilm formation of H. pylori ATCC 
43504 are shown in Table 2. In the control, both pellicle 
and attached biofilm was firstly detected in H. pylori since 
day 3, following by an expansion of bacterial biofilm on 
the continuous days. The fully mature biofilm was clearly 
observed on day 5 and steadily maintained up to day 7 of 
observation. The same characteristic of biofilm produc-
tion appeared in curcumin treated at 1/8, 1/16 and 1/32 
MIC. While, curcumin at 1/4 MIC markedly inhibited bio-
film formation. The complete inhibition of biofilm forma-
tion was demonstrated at 1/2 MIC. DMSO at concen-
tration of 0.016%, which was the highest concentration 
mixed in curcumin suspension, showed no effect against 
H. pylori biofilm production. However, both concen-
trations of 1/4  and  1/2  MIC  were  observed  extensively  
                                                                                                                                      






Figure 1. Photograph of pellicle assay showing 7-day biofilm formed by H. pylori ATCC43504. 
Left test tube, culture grown without curcumin demonstrating mature biofilm at air-liquid interface. 
Two biofilm characteristics were observed, including pellicle (left test tube; arrowed) and attached 




until day 21. It was found that the biofilm production could 
restore after prolong incubation (Table 3). The mature 
biofilm were detected in 1/4 and 1/2 MIC after day 10 and 
day 17, respectively.  
 
 
Quantification of biofilm formation 
 
We quantified level of H. pylori biofilm treated with cur-
cumin at subinhibitory concentrations (1/2 - 1/32 MIC). As 
shown in Figure 2, curcumin significantly decreased the 
biofilm formation in a dose dependent manner. The level 
of biofilm was markedly decreased when treated with cur-
cumin at 1/2 MIC (P < 0.000) and 1/4 MIC (P = 0.001). In 
contrast, the biofilm levels were not significantly different 
between curcumin treated at 1/8, 1/16 and 1/32 MIC in 





We used SEM to document a 3-dimensional structure of 
H. pylori biofilm and compared our SEM images to the 
existing images from other works. The SEM images of 
untreated H. pylori ATCC43504 taken from day 4, 5, 6 
and 7 (Figure 3A-D) revealed uniform biofilm architecture 
with dense accumulations of bacteria within an amor-
phous matrix. The cells connected to each other by long 
fibrils and seemed to form aggregates. The abundant of 
cross-linked fibrils were associated with mature biofilms. 
Moreover, the bacterial morphology changed from 
bacillary to coccoid form in the older culture. In contrast, 
the fiber-like structure was found to adhere to long rod 
shape bacteria in the biofilms from day 7 of curcumin 
treated at 1/4 MIC (Figure 3E). In addition, the 
amorphous substance appeared to be lesser than the 
untreated sample (Figure 3A) with same incubation 
period. While, there was no evidence of biofilm formation 
from 7-day planktonic bacteria of curcumin treated at 1/2 
MIC (Figure 3F). Neither amorphous extracellular sub-
stance nor complex bacterial layers were observed. The 
bacterial cells were found in coccoid-rod mixed popu-
lation and tended to produce fiber-like structure.  Sur-
prisingly, the cell destruction, represented by a pore for-
mation over cell wall surface (Figure 3F; arrowed) 
occurred. While, bacteria grown without 2% (w/v) BCD 
have a filamentous coccoid morphology and flagellar 
could be observed on the surface (Figure 3G). Instead, a 
long bacillary shape was seen from 3-day old colonies 
(Figure 3H).  
                                                                                                                                      




Table 1. Biofilm formation of 14 strains of H. pylori performed by pellicle assay. Two biofilm characteristics were noted including pellicle and attached biofilm. Development of biofilm was 
daily observed and scored through 7 days.  
 






































































































































































































1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
3 + + + + - - - - - - - - - - - - + ++ - - - - - - - - - - 
4 ++ ++ +++ +++ - - - - ++ ++ + + + + + + +++ +++ + + + + + + - - ++ ++ 
5 +++ +++ +++ +++ - - ++ + +++ +++ ++ ++ + + ++ ++ +++ +++ ++ ++ +++ +++ ++ ++ + + +++ +++ 
6 +++ +++ +++ +++ - - ++ ++ +++ +++ ++ ++ ++ ++ ++ ++ +++ +++ ++ ++ +++ +++ ++ ++ ++ ++ +++ +++ 
7 +++ +++ +++ +++ + + +++ +++ +++ +++ ++ ++ ++ ++ +++ +++ +++ +++ +++ +++ +++ +++ ++ ++ ++ ++ +++ +++ 
 
Level of individual biofilm type represent as (-, absent); not any form of biofilm seen, (+, just visible); thin pellicle film or a fine attached biofilm, (++, intermediate); accumulated pellicle of liquid surface or 
a thin attached biofilm, (+++, extensive); a mature pellicle covering whole liquid surface or a dense attached biofilm. Experiments were performed in duplicate on three separated occasions. 




Table 2. Effects of curcumin at subinhibitory concentrations (1/2-1/32 MIC) on H. pylori ATCC43504 biofilm formation. Development of pellicle and/or attached biofilm was daily 
observed for 7 days.  
 
Curcumin concentrations 






















1 - - - - - - - - - - - - - - 
2 - - - - - - - - - - - - - - 
3 + + + + - + - + - - - - + + 
4 ++ ++ ++ ++ + + + + - - - - ++ + 
5 +++ +++ +++ +++ ++ +++ ++ +++ - + - - +++ ++ 
6 +++ +++ +++ +++ +++ +++ ++ +++ + + - - +++ +++ 
7 +++ +++ +++ +++ +++ +++ +++ +++ ++ ++ - - +++ +++ 
 
Level of individual biofilm type represent as -; absent, +; just visible, ++; intermediate, +++; extensive, as described previously in Table 1. Experiments were performed in duplicate on three 
separated occasions. Representative scores were the major scores derived from three separated experiments. 
                                                                                                                                      




Table 3. Effects of curcumin at various incubation times on H. pylori 
ATCC43504 biofilm formation. Biofilm developments were daily observed 
through 21 days in a presence of curcumin at 1/2 and 1/4 MIC.  
 
Curcumin concentration 
0 1/4 MIC 1/2 MIC Day 





1 - - - - - - 
2 - - - - - - 
3 - + - - - - 
4 + + - + - - 
5 ++ +++ - + - - 
6 +++ +++ + + - - 
7 +++ +++ + + - - 
8 +++ +++ ++ ++ - - 
9 +++ +++ ++ +++ - - 
10 +++ +++ +++ +++ - - 
11 +++ +++ +++ +++ - - 
12 +++ +++ +++ +++ - - 
13 +++ +++ +++ +++ - - 
14 +++ +++ +++ +++ - - 
15 +++ +++ +++ +++ + + 
16 +++ +++ +++ +++ ++ ++ 
17 +++ +++ +++ +++ +++ +++ 
18 +++ +++ +++ +++ +++ +++ 
19 +++ +++ +++ +++ +++ +++ 
20 +++ +++ +++ +++ +++ +++ 
21 +++ +++ +++ +++ +++ +++ 
 
Level of individual biofilm type represent as -; absent, +; just visible, ++; 
intermediate, +++; extensive, as described previously in Table 1. Experiments were 
performed in duplicate on three separated occasions. Representative scores were 




Anti-adhesive activity of curcumin against H. pylori 
 
In order to understand the mechanism of the anti-biofilm 
action of curcumin, the ability of H. pylori to adhere, 
which is likely to be the initial step of biofilm formation, 
was investigated. The anti-adhesive activity of curcumin 
was assessed against H. pylori ATCC43504 on HEp-2 
cells. The curcumin at 1/2 MIC, which completely inhibit-
ted biofilm formation of H. pylori on day 7 of observation, 
was tested. A significant inhibition of H. pylori adherence 
was observed with a reduction of 83.2% compared to the 





The ability of H. pylori to produce biofilm is thought to be 
important in facilitating bacteria to survive in adverse 
conditions (Cole et al., 2004; Stark et al., 1999).  Despite 
the environmental limitations of H. pylori isolates, their 
survival in biofilms may play an important role in the 
transmission of the pathogen to humans.  H. pylori has 
been conferred as another pathogen that considered to 
have an evidence for a waterborne route of infection 
(Watson et al., 2004). Here, we demonstrated that H. 
pylori could form biofilm in liquid monoculture with two 
distinct characteristics. It can form a pellicle and attach to 
a glass surface at air-liquid interface indicating the most 
presumable its microaerobic character (Cole et al., 2004). 
Similar forms of biofilms have been observed previously 
in other bacteria such as Campylobacter jejuni (Joshua et 
al., 2006). Although, all the tested H. pylori strains here 
enabled to produce biofilm, the dramatically different bio-
film levels have been observed both in reference and 
clinical isolates. H. pylori ATCC51932, which is cagA 
negative strain, exhibited the lowest biofilm level.  This 
effecter protein, CagA, has been suggested to have a 
role in H. pylori  colonization  (Torres and Backert, 2008).  
                                                                                                                                      


































Figure 2. Biofilm quantification of H. pylori ATCC43504 at subinhibitory concentrations of curcumin. The level of 
biofilm production was quantified by crystal violet staining and subsequently measuring absorbance at 570 nm at 
7 day. Asterisks (*) and (**) indicate significant differences from control at the P = 0.001 and P < 0.000 levels, 
respectively. Experiments were performed in duplicate on three separated occasions. Error bars represent ± 




Also, the cagPAI encodes a type IV secretion system 
(T4SS), has been noted to be associated in attachment 
and invasion of H. pylori into hepatocytes (Ito et al., 
2008). Although postulate of the relevant of this virulent 
factor with biofilm formation has not been elucidated, its 
role in colonization and adhesion may be associated.   
Production of biofilm by H. pylori may be important for 
enabling its resistance to antimicrobials and host defense 
factors (Houben et al., 1999). Treatments with standard 
antibiotics are ineffective at eradicating biofilm-related 
infections. Moreover, the evolution of bacterial resistance 
is very rapid which restricts the use of newer generations 
of antibiotics (Levy, 2002). Therefore, the new strategies 
to overcome biofilm infections have been proposed, for 
example the use of carbohydrate-based therapeutic as 
anti-adhesive (Tenke et al., 2004), the use of 
phytomedicine to prevent biofilm formation (Limsuwan et 
al., 2008; Rasooli et al., 2008) and the use of 
bacteriophage to hydrolyze biofilm extracellular polymers 
(Donlan, 2009). The anti-biofilm activities have been 
demonstrated in a number of medicinal plants (Limsong 
et al., 2004; Duarte et al., 2006; Cartagena et al., 2007; 
Kuzma et al., 2007). In the traditional medicine, turmeric 
is one of the well-known herbs used for gastric ailment 
(Araujo and Leon, 2001). Curcumin, a major compound 
derived from the rhizomes of turmeric, possesses a board 
pharmacological effect (Negi et al., 1999) and confers 
anti-H. pylori activity (Mahady et al., 2002). In the present 
study, its anti-biofilm activity against H. pylori was ob-
served, with dose dependent manner. Although, cur-
cumin effectively inhibited H. pylori biofilm formation, the 
ability could restore in the later period. However, in our 
point of view, curcumin could delay biofilm formation 
making most of bacterial cells being as planktonic, which 
is more sensitive to antimicrobial agents rather than in 
biofilm state (Mah and O’Toole, 2001). Curcumin has 
been shown to down-regulated virulence factors, quorum 
sensing and biofilm initiation genes of Pseudomonas 
aeruginosa (Rudrappa and Bais, 2008). However, the 
precise mechanism of this agent against H. pylori biofilm 
requires further investigation.  
The progression of biofilm formation by H. pylori mimics 
previous reports, beginning with individual bacteria 
adhering to the abiotic surface, expansion into colonies 
and formation of a 3-D structure (Cole et al., 2004). The 
architecture of H. pylori biofilms was observed by SEM 
revealed that the bacteria aggregated together surround-
ed by extracellular polymeric matrix and fibrillar network. 
This observation associates with the mature biofilms 
explained previously (Watnick and Kolter, 2000). The 
ultrastructure of biofilm is comprised of bacterial cells 
encased in biopolymer matrix. The matrix mainly contains 
exopolysaccharide, proteins and DNA (Thomas and 
Lehman, 2006). The polymeric matrix may be responsible 
for the biofilm volume and the protection of biofilm com-
munity (Cvitkovitch et al., 2003). Moreover, most of the 
bacterial cell shape embedded in extracellular polymeric 
matrix changed from rod to coccoid in the older culture.  
This morphological conversion may lead bacteria to a 
dormant stage and a  loss  of  culturability  (Cellini  et  al.,  
                                                                                                                                      







Figure 3. SEM photomicrograph of biofilm development of H. pylori ATCC43504 at a magnification of X 15,000. A-D; pellicle cells taken from 
bacterial culture without curcumin at day 4, 5, 6 and 7, respectively.  E; pellicle cells taken from culture with 1/4 MIC of curcumin on day 7. F; 
planktonic cells taken from culture with 1/2 MIC of curcumin on day 7 show perforations on the cell surface (arrowed). G: bacterial cells taken from 




2007). The bacterium tends to enter the VBNC 
state, which represents a non-growing population 
of cells in microbial biofilms in order to ensure 
firmly adhesion to the surfaces (Lewis, 2005). In 
response to sub-optimum conditions such as sub-
inhibitory drug concentrations, nutrient depletion 
or adverse atmospheres, most of the human 
pathogen (Campylobacter spp., Escherichia coli, 
Francisella tularensis, Legionella pneumophila, 
Listeria monocytogenes, Mycobacterium tubercu-
losis, P. aeruginosa, Salmonella spp., Shigella 
spp., Vibrio cholerae, V. parahaemolyticus, V. 
vulnificus, H. pylori) are able to convert to the 
VBNC form. This bacterial state has been sug-
gested to play a role in recurrent and drug 
resistant infections (Ozcakir, 2007). Noteworthy, 
in the curcumin treated conditions, less amor-
phous substance with retardation of morphological 
change was investigated. Moreover, curcumin at 
1/2 MIC absolutely inhibited the biofilm formation 
and perforation of cells was revealed in the plank-
tonic cells from day 7. This could be associated 
with cell wall and cell membrane damage similar 
in L. monocytogenes, Salmonella typhimurium 
and E. coli exposed to bacteriocins or hydrostatic 
pressures (Kalchayanand et al., 2004). The evi-
dence of cell injury has been observed with plank-
tonic and sessile Bacillus subtilis, Pseudomonas 
fluorescens, P. aeruginosa after treatment with 
sanitizer against biofilms (Lindsay and von Holy, 
1999; DeQueiroz and Day, 2007).  
The attachment is prescribed as the necessary 
initial step in the formation of a biofilm (Joshua et 
al., 2006; Palmer et al., 2007). The ability to ad-
here to stratum could subsequently promote bio-
film establishment. Thus, stopping bacterial adhe-
sion is thought to be one advantage strategy to 
overcome biofilm-associated infections (Bavington 
and Page, 2005). As well as looking at the anti-
biofilm activity, the ability of curcumin to reduce 
adherence of H. pylori to the HEp-2 cells was    
also demonstrated  here.   Consistently,  turmeric 
                                                                                                                                      






Figure 4. Effect of curcumin against H. pylori ATCC43504 adherence to the HEp-2 cells. H. pylori was co-cultured with HEp-2 cells 
for 2 h in a presence of 1/2 MIC of curcumin. Results expressed as the proportion of adherence bacteria versus control.  Proportion 
of adherence bacteria was calculated as the rate of the number of adherence bacteria divided by the bacterial inoculum. Asterisk (*) 
indicates significant difference from control at the P = 0.009 level by pair t-test. Experiments were performed in duplicate on three 




is one out of 3 plants showing to inhibit adhesion of H. 
pylori to the stomach sections previously (O’Mahony et 
al., 2005). And this may results in preventing biofilm 
formation and/or leading to biofilm detachment on human 
gastric mucosa.  
 
 
Conclusion   
 
Curcumin exhibited inhibition of biofilm formation and 
adherence to the human epithelial against H. pylori. The 
virtue of anti-H. pylori property of curcumin could be cru-
cial in inhibition of pathogenesis caused by this organism. 
Hence, curcumin may be a potential supplemental 
material for the treatment of biofilm-involved H. pylori 
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